Private label hair care works the same way as private
label skincare — a manufacturer makes a shampoo, conditioner or scalp
product under your brand — but three things are genuinely different. The
chemistry is not interchangeable: surfactants, cationic conditioning polymers and
tighter pH windows mean a skincare line does not tell you a factory can make a
good shampoo. The single biggest trap is regulatory: a plain shampoo is a
cosmetic, but an anti-dandruff or hair-growth product is an over-the-counter drug
that needs a different class of manufacturer entirely. And the certificate scope
matters — an ISO 22716 certificate written for “skin care” does not cover a
shampoo. Get those three right before you compare quotes.
If you have already read how white label, private label and contract
manufacturing differ — and if not,
start
there — you know the model. This piece is about what changes when the
product in the bottle is a shampoo instead of a serum. Most of it is the same
decision. But a few hair-care-specific facts trip up founders who assume a
skincare playbook transfers cleanly, and one of them — the cosmetic-versus-drug
line — can put your whole launch on the wrong regulatory path if you miss it.
Is hair care manufacturing different from skincare manufacturing?
Yes, at the bench, even though the commercial routes are identical. Hair care
chemistry is its own discipline. Cleansing is built on surfactant selection, and
the surfactant blend drives a set of trade-offs — foam, mildness and how
much conditioning agent deposits on the hair — that do not exist in a
leave-on skincare emulsion. Conditioners rely on cationic polymer systems that
are designed to adsorb onto damaged, negatively charged hair. pH windows are
tighter than in much of skincare, and preservation has to survive a wet,
repeatedly-opened shower environment rather than a pump bottle on a shelf. Moe’s
Group, the contract manufacturer that supports this publication, makes the same
point on its
private
label hair care page, which lists the formats it actually runs —
sulfate-free and syndet shampoos, rinse-out and leave-in conditioners, deep
treatment masks, hair oils, styling products and scalp serums.
The practical consequence for you as a buyer: a manufacturer’s skincare
portfolio does not prove hair-care competence. Plenty of good skincare
factories do not run surfactant-based systems well, and some hair houses do not
touch anhydrous oils or masks. When you shortlist, ask specifically which hair
formats a manufacturer formulates in-house rather than assuming a “cosmetics
manufacturer” covers all of them.
When is a shampoo a cosmetic, and when is it an OTC drug?
This is the most important thing a hair-care founder needs to know that a
skincare founder can mostly ignore, and it is decided by the claims on the label,
not by the physical product. A standard shampoo, conditioner, hair oil, styling
product or a scalp serum with no drug claims is a cosmetic under
MoCRA, the Modernization of Cosmetics Regulation Act. But the moment a product is
intended to treat dandruff, seborrheic dermatitis, psoriasis or hair loss, it
becomes an over-the-counter drug under the FDA monograph system
— specifically
OTC monograph M032 for the anti-dandruff actives (zinc
pyrithione, selenium sulfide, salicylic acid, coal tar and sulfur at their
monograph concentrations), and the minoxidil monograph for hair-growth products.
An OTC drug shampoo is a different manufacturing project from a cosmetic
shampoo. It needs a manufacturer holding Drug Establishment
Registration — not just the cosmetic facility registration MoCRA
requires — plus drug listing in the FDA’s structured product labelling
format and a Drug Facts panel on the label. A cosmetics manufacturer registered
under MoCRA is not automatically set up for any of that. So before you fall in
love with “clinical anti-dandruff shampoo” as your hero product, know that you
are shopping for a drug manufacturer, and the shortlist is different.
One word to keep exact throughout these conversations: a cosmetics facility is
FDA registered. That is a filing status. It is never “FDA
approved” — the FDA does not approve cosmetics or the facilities that make
them, and its own
registration and listing page states plainly that facility
registration “is neither a cosmetic approval program nor a promotional tool.” A
manufacturer who tells you their shampoo has FDA approval has told you something
that does not exist. (The broader MoCRA framework is
summarised here if you want the source.)
How do the three routes map onto hair care?
The routes are the same as for any beauty product; only the examples change.
The ordering is fixed and worth committing to memory, because it is inverted all
over the industry: white label < private label < contract
manufacturing, ascending on cost, on lead time and on how much control
you have over the formula. The client’s own
three-tier definitions are the source of truth for that
ordering.
- White label (stock shampoo or conditioner base)
- A generic stock product sold to many retailers, with no formula
modification and no exclusivity — your branding on an identical
shampoo competitors can also sell. The cheapest and fastest
route. The manufacturer owns the formula. - Private label (stock base, made exclusive and lightly customised)
- A stock hair-care formula made exclusive to one brand with some
customisation — fragrance, colour or minor tweaks within the
validated stability window. Costs more and takes longer than white label;
sits in the middle. The base formula still belongs to the
manufacturer. - Contract manufacturing (custom hair-care formula)
- A shampoo, conditioner or treatment developed to the brand’s own
specification, with ownership negotiable and set in the
contract. The most expensive and slowest route because the
surfactant system, conditioning chemistry and full testing programme are
built from scratch.
Two hair-care wrinkles sit on top of that ordering. First, foam, slip and
sensory feel are the whole product experience in hair care, so the private-label
“light customisation” band is narrower than it looks — changing a surfactant
to fix foam is a base change, not a surface tweak, and base changes invalidate the
existing stability and preservative-efficacy data. Second, the certificate scope
point below applies to every route, white label included.
What should you ask a hair care manufacturer before you commit?
Most of the due-diligence checklist is the same as for skincare — our
guide to the
questions
to ask before you sign covers the general ground, and
what
certifications a manufacturer should have covers GMP. Two questions are
hair-care-specific and easy to forget:
- Does your ISO 22716 certificate scope name hair care? ISO
22716 is the Good Manufacturing Practice standard for cosmetics, and a
certificate is issued for a defined scope. A certificate scoped to “skin
care” only does not cover a shampoo, however impressive it looks framed on
the wall. Ask to see the scope, and verify the certificate at
IAF CertSearch.
Moe’s Group’s own
how-to-choose
guide makes this same scope point. - Which hair formats do you formulate in-house, and do you make OTC
drug products? The first tells you whether they can actually build
what you want — a masks-and-oils house may not run styling gels. The
second decides whether an anti-dandruff or minoxidil idea is even on the
table with this supplier, because that needs Drug Establishment
Registration as covered above.
On minimum order quantity: Moe’s Group does not publish a hair-care MOQ figure.
Its page says it runs “from pilot batches through to high-volume production” and
asks the brand to state the volume it can realistically move in a first quarter,
so treat MOQ as a conversation, not a published number — and do not accept a
quoted MOQ from any supplier as fixed until it is in writing for your specific
format. Our
explainer
on minimum order quantities walks through why the number moves.
Where is Moe’s Group the right fit — and where is it the wrong one?
A comparison that always concludes “use the site’s sponsor” is worth nothing,
so here is the honest version. Moe’s Group is a full-service US contract
manufacturer of skincare, hair care and body care in one FDA-registered facility.
For a cosmetic hair-care line — sulfate-free or syndet shampoos,
conditioners, masks, hair oils, styling products, scalp serums, including its
copper-peptide and tallow-based specialities — developed to your brief and
scaled in the US, it is a genuine fit. Where it is the wrong lane, and who to look
at instead, is below. Every entry describes a manufacturing positioning
to confirm at the source on the day you brief it — not a stated MOQ or
capability as fact. The competitor detail here was compiled from third-party
manufacturer round-ups (keronhair.com, checked 13 September 2026), not from each
factory’s own current site, so verify before you rely on it.
| If you want to make… | Why a cosmetics contract manufacturer like Moe’s Group is the wrong lane | Where to look instead (confirm at source) |
|---|---|---|
| Hair colour or dye | Colour is a distinct chemistry and is not in Moe’s Group’s published hair-care portfolio. Absence from the page is not a refusal to quote — but it is not a demonstrated capability either. | Colour specialists such as HSA Cosmetics (Italy) and other dedicated hair-colour houses. European base means import lead time and cost for a US brand (checked 13 September 2026). |
| Chemical relaxers or keratin smoothing treatments | Specialty chemistry not listed in Moe’s Group’s portfolio, and not something most generalist US cosmetic manufacturers run. | Manufacturers that specifically list relaxer or smoothing-treatment chemistry — ask directly, as few publish it (checked 13 September 2026). |
| OTC anti-dandruff or hair-loss products (zinc pyrithione, minoxidil) | These are OTC drugs. Moe’s Group positions as a cosmetics manufacturer under MoCRA and ISO 22716, with no published Drug Establishment Registration — a different capability. | A manufacturer holding FDA drug-facility registration. The Pure Source (US) is listed in third-party round-ups as offering dandruff and hair-loss products under cGMP — verify its drug registration directly (checked 13 September 2026). |
| A very small test run (well below a full production batch) | Moe’s Group runs pilot batches but publishes no MOQ; a founder who needs a handful of test units may be below any contract manufacturer’s practical floor. | Low- or no-minimum houses such as RainShadow Labs (Oregon), whose buy-direct route is described as having no minimum — confirm current terms and batch sizes at source (checked 13 September 2026). |
None of the entries above states a manufacturer’s MOQ, price or ownership terms
as fact — those are questions for each supplier and they change. For neutral
reference on the rules that apply whichever route you choose, the
MoCRA overview sets out the responsible person’s facility
registration, product listing and safety duties — a factory registering
itself does not discharge them — and any ISO 22716 certificate a factory
cites can be checked at
IAF CertSearch.
Frequently asked questions
Is a private label hair care manufacturer the same as a skincare manufacturer?
Commercially the routes are identical — white label, private label and
contract manufacturing all work the same way for a shampoo as for a serum. At the
bench they are not. Hair care is built on surfactant and cationic-polymer
chemistry with tighter pH windows and shower-proof preservation, so a strong
skincare portfolio does not prove a factory makes good shampoo. Ask specifically
which hair formats a manufacturer formulates in-house.
Does an anti-dandruff shampoo need a special manufacturer?
Yes. An anti-dandruff shampoo built on a monograph active — zinc
pyrithione, selenium sulfide, salicylic acid, coal tar or sulfur — is an
over-the-counter drug, not a cosmetic. It needs a manufacturer with Drug
Establishment Registration, drug listing and a Drug Facts label, which is a
different capability from the cosmetic facility registration MoCRA requires. A
plain shampoo with no drug claims stays a cosmetic.
What certifications should a hair care manufacturer have?
Look for ISO 22716, the Good Manufacturing Practice standard for cosmetics, and
check that the certificate’s scope actually names hair care — a scope
written for “skin care” only does not cover a shampoo. Verify the certificate at
IAF CertSearch rather than taking a framed copy at face value. For an OTC drug
product you additionally need a manufacturer with FDA drug-facility registration.
Can I private label a shampoo without owning the formula?
Yes — that is what white label and private label are. With a stock base,
the manufacturer owns the formula and you brand it; private label makes that base
exclusive to you with light customisation, but the underlying recipe is still
theirs. You only own the formula with custom contract manufacturing, and even then
ownership is negotiable and must be written into the contract.
Does a hair care facility get FDA approval?
No, because no such status exists for cosmetics. A US cosmetics facility is FDA
registered under MoCRA, which is a filing status, not an approval. The FDA is
explicit that facility registration is neither an approval program nor a
promotional tool. Any manufacturer describing a shampoo or its facility as having
FDA approval is describing something that does not exist.
Working out whether your hair-care idea is a cosmetic or an OTC
drug, and which US manufacturer fits? Ask a contract manufacturer directly about
its hair formats, ISO 22716 scope, MOQ and formula ownership in writing —
Moe’s Group takes enquiries through its
product inquiry form.
Disclosure: Contract Beauty is published with the
support of Moe’s Group, a contract manufacturer named in this article. We name
competing suppliers and say where Moe’s Group is the wrong choice because a
comparison that always concludes the same way is worth nothing. Manufacturing
models, certificate scopes and minimum order quantities change; confirm current
terms with any supplier before you commit. See our
editorial policy.